SciTransfer
Organization

CENTRUM MATERIALOW POLIMEROWYCH IWEGLOWYCH POLSKA AKADEMIA NAUK*CMPIW PAN

Polish Academy polymer research centre developing biopolymeric nanoparticles for cancer therapy and biodegradable materials for medical packaging.

Research institutehealthPLNo active H2020 projectsThin data (2/5)
H2020 projects
3
As coordinator
2
Total EC funding
€497K
Unique partners
8
What they do

Their core work

CMPIW PAN is a research centre within the Polish Academy of Sciences specializing in polymer and carbon materials. Their H2020 work focuses on two applied domains: developing biodegradable polymers from renewable resources for medical and packaging applications, and engineering biopolymeric nanoparticle systems for cancer photodynamic therapy. They operate primarily through Marie Skłodowska-Curie researcher exchange and fellowship programmes, indicating a strong emphasis on building international research talent in advanced polymer science.

Core expertise

What they specialise in

Biopolymeric nanoparticles for cancer therapyprimary
2 projects

Two BIOnanoPDT projects (coordinator role) developing phthalocyanine-loaded polymeric nanoparticle delivery systems for breast cancer photodynamic therapy.

Biodegradable polymers for medical and packaging usesecondary
1 project

GREEN-MAP project focused on green polymeric materials for hospital packaging and medical disposables from renewable resources.

Photodynamic therapy photosensitizersemerging
2 projects

Both BIOnanoPDT projects centre on phthalocyanines as photosensitizers, suggesting growing depth in this photochemistry niche.

Evolution & trajectory

How they've shifted over time

Early focus
Green biodegradable packaging polymers
Recent focus
Cancer nanomedicine delivery systems

All three projects started in 2020, so the timeline is compressed, but a clear thematic shift is visible. The earlier-period keywords (biodegradable polymers, renewable resources, packaging) reflect industrial sustainability applications, while the more recent focus (polymeric nanoparticles, phthalocyanines, breast cancer, photodynamic therapy) points toward biomedical applications. This suggests CMPIW PAN is pivoting its polymer expertise from green materials toward nanomedicine and therapeutic delivery systems.

CMPIW PAN is moving from industrial polymer applications toward biomedical nanomaterials, specifically nanoparticle drug delivery for oncology — a direction likely to intensify given their coordinator investment in BIOnanoPDT.

Collaboration profile

How they like to work

Role: consortium_leaderReach: European6 countries collaborated

With 2 out of 3 projects as coordinator, CMPIW PAN clearly prefers to lead rather than follow — unusual for a small research centre with limited H2020 history. Their projects are funded through MSCA schemes (individual fellowships and staff exchanges), meaning they build collaborations through researcher mobility rather than large technology consortia. With 8 unique partners across 6 countries from just 3 projects, they maintain a broad but shallow network typical of MSCA-driven institutions.

They have collaborated with 8 distinct partners across 6 countries through just 3 projects, indicating a well-distributed European network. The MSCA-RISE scheme in particular suggests active researcher exchange links with multiple institutions internationally.

Why partner with them

What sets them apart

CMPIW PAN sits at an unusual intersection: they bring deep polymer chemistry expertise to both sustainability (green packaging) and oncology (nanoparticle drug delivery). This dual capability is rare — most polymer labs specialize in either industrial materials or biomedical applications, not both. For consortium builders, they offer a credible Polish Academy of Sciences partner with hands-on experience coordinating MSCA projects and a growing nanoparticle delivery platform.

Notable projects

Highlights from their portfolio

  • BIOnanoPDT
    Coordinated by CMPIW PAN, this project combines biopolymer nanoparticles with phthalocyanine photosensitizers for breast cancer therapy — a distinctive niche at the polymer-oncology boundary.
  • GREEN-MAP
    Addresses hospital sustainability by replacing conventional medical packaging and disposables with biodegradable polymers from renewable resources — a growing regulatory priority in healthcare.
Cross-sector capabilities
environmentmanufacturingfood
Analysis note: Only 3 projects (all starting 2020), two of which appear to be the same BIOnanoPDT project with different end dates (possibly a continuation or data duplication). The small dataset limits confidence in trend analysis. The keyword shift is real but compressed into a single year, so the 'evolution' may reflect parallel interests rather than a true pivot.